Here’s a pretty good article. The Marketing of a Disease: Female Sexual Dysfunction by investigative journalist Ray Moynihan that appeared in the British Medical Journal.
[QUOTE=Ray Moynihan]
…The first step in promoting a blockbuster drug is to build the market by raising public awareness about the condition the drug is designed to target. In anticipation of regulatory approval of its testosterone patch—the first drug assessed for female sexual dysfunction—Proctor and Gamble unleashed a multilayered global marketing campaign. It sponsored key scientific meetings in sexual medicine, hired leading sex researchers as consultants, funded continuing medical education activities, produced a reporter’s guide to testosterone, and created a publicly accessible website. It has worked with agents from three public relations companies and at least one major advertising firm to promote awareness of both the “disease” and the drug.
Proctor and Gamble’s patch spokesperson, Elaine Plummer, told me that this is “Not an exceptional amount of firepower.” Some industry reports suggest, however, that the company may have already set aside an initial $100m (£53m, €76m) to spend on advertising alone. Long before its testosterone patch had even been assessed for approval, the company’s global marketing had been strategically targeting health professionals, reporters, and the general public, seeking to shape their perceptions of female sexual problems and how to treat them.
“The product the company is selling at this stage is really the disease,” argues Leonore Tiefer, a psychologist and clinical associate professor at New York University School of Medicine. “I think Proctor and Gamble has a marketing plan that worked for shampoo. Create a buzz, get the word out, heighten consciousness, get people talking,” she said. Since it has been hoping to have the first approved drug solution, says Tiefer, “it only has to get people talking about the condition, and present it as amenable to a drug intervention. Then it won’t be seen as the company pushing its product, it will be seen as health education.”
…
[/QUOTE]
The documentary showed the FDA hearing where P&G’s testosterone patch was turned down for approval by a unanimous vote. It was pretty hilarious to think that P&G spent all that money for nothing, but depressing to think that so many real diseases, including many affecting women, get no funding at all.